Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Cardiac Drug Therapy - M. Gabriel Khan

Cardiac Drug Therapy

(Autor)

Buch | Softcover
791 Seiten
2014 | 8th ed. 2015
Humana Press Inc. (Verlag)
978-1-61779-961-7 (ISBN)
CHF 239,65 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
This book is an essential guide to the medical treatment of the cardiac patient and presents core principles of cardiovascular therapeutics as well as drug recommendations. Major classes of drugs are featured, including beta-blockers, ACE inhibitors, calcium antagonists, diuretics, and antiplatelet agents and unique insights into the controversies surrounding the use of specific drugs are explored, with answers given to the question: do beta blockers and diuretics really cause diabetes? Properties, dosage, side effects, potential salutary benefits, and drawbacks on virtually all commercially available cardiac drugs are examined. This revised edition is thoroughly updated and addresses the entire spectrum of heart disorders, such as hypertension, angina, myocardial infarction, heart failure, arrhythmias, cardiac arrest, and dyslipidemias. New chapters include endocrine heart diseases, management of cardiomyopathies, and newer agents. In addition, topics such as cardiac drugs in pregnancy and lactation and drug interactions are covered. Cardiac Drug Therapy, Eighth Edition, is an authoritative and clinically relevant resource for cardiologists, cardiology fellows, and internists.

Dr. M. Gabriel Khan is a cardiologist at the Ottawa Hospital and an Associate Profes­sor of Medicine, at the University of Ottawa. Dr. Khan graduated MB, BCh, with First-Class Honours at The Queen’s University of Belfast. He obtained , by thesis, the Degree  of  Doctor of Medicine  with  Honours ( QUB). He is the author of Encyclopedia of Heart Diseases, Academic Press/ Elsevier, 2006; Encyclopedia of Heart Diseases,  2nd ed., Springer Science+Business Media,  2011; Rapid ECG Interpretation, 3rd ed.,  Humana Press/Springer Science+Business Media, 2008;  On Call Cardiology, 3rd  ed., Elsevier, 2006; Heart Disease Diagnosis and Therapy, 2nd ed., Humana Press, 2006; Cardiac and Pulmonary Management (1993); Medical Diagnosis and Therapy (1994); Heart Attacks, Hypertension and Heart Drugs (1986); and Heart Trouble Encyclopedia (1996).

Beta-Blockers: The Cornerstone of Cardiac Drug Therapy.- Beta-Blocker Controversies.- Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers.- ACE Inhibitor Controversies.- Calcium Antagonists (Calcium Channel Blockers).- Calcium Antagonist Controversies.- Diuretics.- Hypertension.- Hypertension Controversies.- Angina.- Acute Myocardial Infarction.- Heart Failure.- Heart Failure Controversies.- Management of Cardiac Arrhythmias.- Cardiac Arrest.- Management of Infective Endocarditis.- Dyslipidemias.- Endocrine Heart Diseases.- Antiplatelet Agents, Anticoagulants, Factor XA Inhibitors, Thrombin Inhibitors.- Cardiac Drugs During Pregnancy and Lactation.- Effects of Drug Interactions.- Hallmark Clinical Trials.- Management of Cardiomyopathies.- Newer Agents.

Reihe/Serie Contemporary Cardiology
Zusatzinfo 6 Illustrations, color; 38 Illustrations, black and white; XXXII, 791 p. 44 illus., 6 illus. in color.
Verlagsort Totowa, NJ
Sprache englisch
Maße 127 x 203 mm
Themenwelt Medizin / Pharmazie Gesundheitswesen
Medizinische Fachgebiete Innere Medizin Kardiologie / Angiologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Schlagworte ACE Inhibitor • Antiplatelet • Beta-Blocker • Cardiac • Cardiology • clinical trial • Drug • heart • Hypertension • Management • Myocardial Infarction • PCI • Pregnancy • Statin
ISBN-10 1-61779-961-0 / 1617799610
ISBN-13 978-1-61779-961-7 / 9781617799617
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
in Fällen, Fragen und Antworten

von Christoph Spes; Volker Klauss; Sibylle Tönjes

Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 124,60

von Julia Christ

Buch | Softcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80